Inhibikase Therapeutics Eulerpool News

Inhibikase Therapeutics Eulerpool News

Inhibikase Therapeutics Aktie News

Inhibikase Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Inhibikase Therapeutics News stellen wir hier zusammen.

• 16. August ·

  GuruFocus
  Inhibikase Therapeutics Inc (IKT) Q2 2024 Earnings Call Transcript Highlights: Improved ...
• 15. August ·

  SeekingAlpha
  Inhibikase Therapeutics, Inc. (IKT) Q2 2024 Earnings Call Transcript
• 15. August ·

  Seeking Alpha
  Inhibikase Therapeutics GAAP EPS of -$0.66 beats by $0.01
• 14. August ·

  Yahoo
  Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
• 14. August ·

  InvestorPlace
  IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024
• 14. August ·

  Thefly.com
  Inhibikase Therapeutics reports Q2 EPS (66c), consensus (67c)
• 7. August ·

  Yahoo
  Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
• 18. Juni ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Inhibikase Therapeutics (IKT) and Intra-Cellular Therapies (ITCI)
• 18. Juni ·

  Seeking Alpha
  Inhibikase Therapeutics files to sell 4.76M shares of common stock for holders
• 17. Juni ·

  Yahoo
  Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease